138 related articles for article (PubMed ID: 17559807)
21. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
22. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence anisotropy: a method for early detection of Alzheimer beta-peptide (Abeta) aggregation.
Allsop D; Swanson L; Moore S; Davies Y; York A; El-Agnaf OM; Soutar I
Biochem Biophys Res Commun; 2001 Jul; 285(1):58-63. PubMed ID: 11437372
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells.
Hossain S; Hashimoto M; Katakura M; Miwa K; Shimada T; Shido O
J Neurochem; 2009 Oct; 111(2):568-79. PubMed ID: 19686246
[TBL] [Abstract][Full Text] [Related]
25. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease.
Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
J Neurochem; 2003 Oct; 87(1):172-81. PubMed ID: 12969264
[TBL] [Abstract][Full Text] [Related]
26. Garlic extract exhibits antiamyloidogenic activity on amyloid-beta fibrillogenesis: relevance to Alzheimer's disease.
Gupta VB; Indi SS; Rao KS
Phytother Res; 2009 Jan; 23(1):111-5. PubMed ID: 18844255
[TBL] [Abstract][Full Text] [Related]
27. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.
Harper JD; Wong SS; Lieber CM; Lansbury PT
Biochemistry; 1999 Jul; 38(28):8972-80. PubMed ID: 10413470
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
[TBL] [Abstract][Full Text] [Related]
29. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
Dolphin GT; Chierici S; Ouberai M; Dumy P; Garcia J
Chembiochem; 2008 Apr; 9(6):952-63. PubMed ID: 18330854
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
[TBL] [Abstract][Full Text] [Related]
31. Visualization and classification of amyloid beta supramolecular assemblies.
Yagi H; Ban T; Morigaki K; Naiki H; Goto Y
Biochemistry; 2007 Dec; 46(51):15009-17. PubMed ID: 18044976
[TBL] [Abstract][Full Text] [Related]
32. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Yoshiike Y; Takashima A; Yamada M; Naiki H
J Neurochem; 2002 May; 81(3):434-40. PubMed ID: 12065652
[TBL] [Abstract][Full Text] [Related]
33. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
Jiao Y; Yang P
J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
[TBL] [Abstract][Full Text] [Related]
35. Estrogen protects peripheral and cerebral blood vessels from toxicity of Alzheimer peptide amyloid-beta and inflammatory reaction.
Thomas T; Rhodin JA; Sutton ET; Bryant MW; Price JM
J Submicrosc Cytol Pathol; 1999 Oct; 31(4):571-9. PubMed ID: 10685397
[TBL] [Abstract][Full Text] [Related]
36. Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors.
Goldsbury CS; Wirtz S; Müller SA; Sunderji S; Wicki P; Aebi U; Frey P
J Struct Biol; 2000 Jun; 130(2-3):217-31. PubMed ID: 10940227
[TBL] [Abstract][Full Text] [Related]
37. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
38. Binding of trypsin to fibrillar amyloid beta-protein.
Chander H; Chauhan A; Wegiel J; Malik M; Sheikh A; Chauhan V
Brain Res; 2006 Apr; 1082(1):173-81. PubMed ID: 16510132
[TBL] [Abstract][Full Text] [Related]
39. Design and biological activity of beta-sheet breaker peptide conjugates.
Rocha S; Cardoso I; Börner H; Pereira MC; Saraiva MJ; Coelho M
Biochem Biophys Res Commun; 2009 Mar; 380(2):397-401. PubMed ID: 19250644
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of beta-amyloid peptide aggregation and neurotoxicity by alpha-d-mannosylglycerate, a natural extremolyte.
Ryu J; Kanapathipillai M; Lentzen G; Park CB
Peptides; 2008 Apr; 29(4):578-84. PubMed ID: 18304694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
